Class IITerminatedD-0194-2021
Drug recall · January 13, 2021
Glycopyrrolate 1 mg/5mL recall
Why: Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Glycopyrrolate 1 mg/5mL (0.2mg/mL), 5 mL Single Dose Syringe, Rx Only, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT, 06095, barcode 70004063809
- Lots / codes
Lot # 1220023043, BUD 2/3/2021; 1220023141, BUD 2/9/2021; 1220023429, BUD 2/18/2021 & 1220023470, BUD 2/18/2021.
- Quantity
- 1,614 syringes
- Company
- SCA Pharmaceuticals, Windsor, CT
- Distribution
- Product was distributed to hospitals nationwide.
- Initiated
- December 17, 2020 · Voluntary: Firm initiated
- Classified
- January 7, 2021
- Reported
- January 13, 2021
- Ended
- November 2, 2021
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Class IITerminatedJan 13, 2021Atropine Sulfate InjectionSCA Pharmaceuticals · D-0186-2021Class IITerminatedJan 13, 2021Buffered Lidocaine HClSCA Pharmaceuticals · D-0187-2021Class IITerminatedJan 13, 2021ePHEDrine SulfateSCA Pharmaceuticals · D-0188-2021Class IITerminatedJan 13, 2021ePHEDrine Sulfate 50 mg/10mL in 0.9% Sodium Chloride InjectionSCA Pharmaceuticals · D-0189-2021Class IITerminatedJan 13, 2021Esmolol HCl 100 mg/10 mLSCA Pharmaceuticals · D-0190-2021Class IITerminatedJan 13, 2021fentaNYL 100 mcg/50mL Ropivacaine HCl 0.1% in 0.9% Sodium Chloride 50 mLSCA Pharmaceuticals · D-0191-2021Class IITerminatedJan 13, 2021fentaNYL 100 mcg/50mL Bupivacaine HCl 0.125% in 0.9% Sodium Chloride 50 mLSCA Pharmaceuticals · D-0192-2021Class IITerminatedJan 13, 2021fentaNYL 1500 mcg/30 mLSCA Pharmaceuticals · D-0193-2021Class IITerminatedJan 13, 2021HYDROmorphone HCl 6 mg/30mL in 0.9% Sodium Chloride InjectionSCA Pharmaceuticals · D-0195-2021Class IITerminatedJan 13, 2021HYDROmorphone HCl 30 mg/30 mL in 0.9% Sodium Chloride InjectionSCA Pharmaceuticals · D-0196-2021Class IITerminatedJan 13, 2021Ketamine 100 mg/10mL in 0.9% Sodium Chloride InjectionSCA Pharmaceuticals · D-0197-2021Class IITerminatedJan 13, 2021labetalol HCl 20 mg/4 mLSCA Pharmaceuticals · D-0198-2021
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.